Early adoption of injectable naltrexone for alcohol-use disorders: Findings in the private-treatment sector

Journal of Studies on Alcohol and Drugs

Volumn 71, Issue 3, 2010, Pages 460-466

  Abraham, Amanda J ^a   Roman, Paul M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952070174     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2010.71.460     Document Type: Article

References (31)

1. Agency for Health Care Policy and Research. (1999). Pharmacotherapy for alcohol dependence (Evidence report/technology assessment no. 3, AHCPR Publication No. 99-E004). Rockville, MD: Author.
2. Center for Substance Abuse Treatment. (1998). Naltrexone and alcoholism treatment. (Treatment Improvement Protocol [TIP] Series 28, DHHS Publication No. [SMA] 98-3206), Rockville, MD: Substance Abuse and Mental Health Services Administration.
3. Ducharme, L. J., Knudsen, H. K., & Roman, P. M. (2006). Trends in the adoption of medications for alcohol dependence. Journal of Clinical Psychopharmacology, 26 (Suppl. No. 1), S13-S19.
4. Fuller, B. E., Rieckmann, T., McCarty, D., Smith, K. W., & Levine, H. (2005). Adoption of naltrexone to treat alcohol dependence. Journal of Substance Abuse Treatment, 28, 273-280.
5. Garbutt, J. C., Kranzler, H. R., O'Malley, S. S., Gastfriend, D. R., Pettinati, H. M., Silverman, B. L., Ehrich, E. W. (2005). Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: A randomized controlled trial. Journal of the American Medical Association, 293, 1617-1625.
6. Gastfriend, D. R., Dong, Q., Loewy, J., Silverman, B., & Ehrich, E. W. (2005). Effect of long-acting injectable naltrexone on durability of drinking outcomes [Abstract]. Alcoholism: Clinical and Experimental Research, 29 (5 Suppl.) 77A.
7. Harris, K. H., DeVries, A., & Dimidjian, K. (2004). Datapoints: Trends in naltrexone use among members of a large private health plan. Psychiatric Services, 55, 221.
8. Heinrich, C. J., & Hill, C. J. (2008). Role of state policies in the adoption of naltrexone for substance abuse treatment. Health Services Research, 43, 951-970.
9. Hermos, J. A., Young, M. M., Gagnon, D. R., & Fiore, L. D. (2004). Patterns of dispensed disulfiram and naltrexone for alcoholism treatment in a veteran patient population. Alcoholism: Clinical and Experimental Research, 28, 1229-1235.
10. Knudsen, H. K., Ducharme, L. J., & Roman, P. M. (2007). The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters. Drug and Alcohol Dependence, 87, 164-174.
11. Knudsen, H. K., & Roman, P. M. (2004). Modeling the use of innovations in private treatment organizations: The role of absorptive capacity. Journal of Substance Abuse Treatment, 26, 353-361.
12. Kranzler, H. R., Stephenson, J. J., Montejano, L., Wang, S., & Gastfriend, D. R. (2008). Persistence with oral naltrexone for alcohol treatment: Implications for health-care utilization. Addiction, 103, 1801-1808.
13. Kranzler, H. R., Wesson, D. R., & Billot, L. (2004). Naltrexone depot for treatment of alcohol dependence: A multicenter, randomized, placebocontrolled clinical trial. Alcoholism: Clinical and Experimental Research, 28, 1051-1059.
14. Lapham, S., Forman, R., Alexander, M., Illeperuma, A., & Bohn, M. J. (2009). The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients. Journal of Substance Abuse Treatment, 36, 1-6.
15. Long, J. S., & Freese, J. (2006). Regression models for categorical dependent variables using Stata (2nd ed.). College Station, TX: Stata Corporation.
16. Mark T. L., Kranzler, H. R., & Song, X. (2003a). Understanding US addic-tion physicians' low rate of naltrexone prescription. Drug and Alcohol Dependence, 71, 219-228.
17. Mark, T. L., Kranzler, H. R., Song, X., Bransberger, P., Poole, V. H., & Crosse, S. (2003b). Physicians' opinions about medications to treat alcoholism. Addiction, 98, 617-626. (Pubitemid 36638200)
18. Mee-Lee, D. L., Gartner, L., Miller, M. M., Shulman, G. D., & Wilford, B. B. (1996). Patient placement criteria for the treatment of substance-related disorders (2nd ed.) Chevy Chase, MD: American Society of Addiction Medicine.
19. National Institute on Alcohol Abuse and Alcoholism. (2005). Helping patients who drink too much: A clinician's guide (updated 2005 ed., NIH Publication No. 05-3769). Bethesda, MD: Author.
20. National Institute on Drug Abuse. (1999). Principles of drug addiction treatment: A research based guide (NIH Publication No. 99-4180).Bethesda, MD: Author.
21. O'Brien, C. P. (2005). Anticraving medications for relapse prevention: A possible new class of psychoactive medications. American Journal of Psychiatry, 162, 1423-1431.
22. O'Malley, S., Garbutt, J. C., Gastfriend, D. R., Qunming, D., & Kranzler, H. R. (2007). Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent prior to treatment. Journal of Clinical Psychopharmacology, 27, 507-512.
23. Oser, C. B., & Roman, P. M. (2007). Organizational-level predictors of adoption across time: Naltrexone in private substance-use disorders treatment centers. Journal of Studies on Alcohol, 68, 852-861.
24. Oser, C. B., & Roman, P. M. (2008). A categorical typology of naltrexone-adopting private substance abuse treatment centers. Journal of Substance Abuse Treatment, 34, 433-442.
25. Rogers, E. M. (2003). The diffusion of innovations (5th ed.). New York: Free Press.
26. Roman, P. M., & Johnson, J. A. (2002). Adoption and implementation of new technologies in substance abuse treatment. Journal of Substance Abuse Treatment, 22, 211-218.
27. Thomas, C. P., Wallack, S. S., Lee, S., McCarty, D., & Swift, R. (2003). Research to practice: Adoption of naltrexone in alcoholism treatment. Journal of Substance Abuse Treatment, 24, 1-11.
28. Thomas, S., & Miller, P. M. (2007). Knowledge of attitudes about pharma-cotherapy for alcoholism: A survey of counselors and administrators in community-based addiction treatment centers. Alcohol, 42, 113-118.
29. Thomas, S., Miller, P. M., Randall, P. K., & Book, S. W. (2008). Improving acceptance of naltrexone in community addiction treatment centers: A pilot study. Journal of Substance Abuse Treatment, 35, 260-268.
30. Webb, M. C., Wilson, J. R., & Chong, J. (2004). An analysis of quasi-complete binary data with logistic models: Applications to alcohol abuse data. Journal of Data Science, 2, 273-285.
31. White, W. (1998). Slaying the dragon. Bloomington, IL: Chestnut Health Systems.